The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023
Drug & Device Law
DECEMBER 29, 2023
2023) (federal government may unilaterally obtain dismissal of FCA claims, and calling the constitutionality of the FCA’s private enforcement mechanism into question) ( here ); Quishenberry v. Instead, Zofran turned mainly on animal studies – three Japanese studies that were not “newly acquired information” that could avoid preemption.
105 
Let's personalize your content